🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$EDIT

Editas Medicine Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 11, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP2.73%
MAX GAP RECORD15.58%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR EDIT

AI REPORT Jul 09

Navigating Overnight Gaps: A Comprehensive Guide to Trading Strategies

AnalysisText… In the volatile world of financial markets, one of the most challenging aspects for traders is managing…
VIEW REPORT_
AI REPORT Jul 06

Weekly Recap: Markets React to AI Rout and Geopolitical Shifts

Analysis Markets experienced a volatile week, with major indices showing significant declines as concerns over $AI developments in…
VIEW REPORT_
AI REPORT Jul 02

Sector Rotation: Where Institutional Money is Flowing

Analysis Markets are currently experiencing a period of heightened volatility, with sector rotation playing a pivotal role in…
VIEW REPORT_